Valeo Financial Advisors, LLC Synthetic Biologics, Inc. Transaction History

Valeo Financial Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 20, 2020	SELL	$2.8 - $5.7 $0 - $0	0 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$2.7 - $6.1 $2,316 - $5,233	-858 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$20.4 - $80.5 $17,503 - $69,069	858 New	858 $1,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.